Kronos Bio, Inc. Asset Impairment Charges
Kronos Bio, Inc. reported Asset Impairment Charges of $300.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2025-05-08
- Kronos Bio, Inc. asset impairment charges for the quarter ending 2025-03-31 was $300.00K, a 95.45% decline year-over-year.
- Kronos Bio, Inc. asset impairment charges for the quarter ending 2024-03-31 was $6.60M.
- Kronos Bio, Inc. asset impairment charges for the quarter ending 2023-09-30 was $0.00.
- Kronos Bio, Inc. asset impairment charges for the quarter ending 2023-03-31 was $0.00.
- Kronos Bio, Inc. asset impairment charges for fiscal 2024 was $18.70M, a 484.38% increase from fiscal 2023.
- Kronos Bio, Inc. asset impairment charges for fiscal 2023 was $3.20M.
- Kronos Bio, Inc. asset impairment charges for fiscal 2022 was $0.00.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2025-03-31 | $300.00K 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $18.70M 10-K · filed 2025-03-18 | |||
| 2024-03-31 | $6.60M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $3.20M 10-K · filed 2025-03-18 | |||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-05-09 | $0.00 derived: sum of 3 quarters · filed 2024-05-09 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 |